No fee unless we recover compensation for your family Text size 833-4-ASBESTOS (833-427-2378) Free Case Review

Asbestos exposure: challenges for Australian clinicians

Our plain-English summary of Asbestos exposure: challenges for Australian clinicians, by A.W. Musk, N.H. de Klerk, A.K. Nowak (The Medical Journal of Australia, 2016).

You don't need the product names or old records. No fee unless we recover compensation for your family.

Call 833-4-ASBESTOS Request a review

The study

In plain English

This is a commissioned editorial, not an original study. The authors gave their views on asbestos-related disease in Australia and drew on other published work. They wrote that pleural plaques, increasingly found on CT scans, are not as such a risk factor for pleural malignant mesothelioma or bronchogenic cancer, although known exposure causes anxiety. Citing the Australian Mesothelioma Registry, they reported that mesothelioma rates had levelled off at around 50 per million per year in men and tenfold less in women. They also wrote that claimants were increasingly presenting with mesothelioma arising solely from domestic exposure. They noted that asbestosis cannot be told apart from other lung fibrosis except by evidence of asbestos exposure. Citing earlier research, they wrote that mesothelioma risk was doubled in first-degree relatives of cases. They described mesothelioma as universally fatal, with a median survival of 9–12 months. The authors wrote that most people with disabling asbestos-related disease are compensated. They argued that differing general damages awards across jurisdictions made a strong case for a national approach.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

What the study did and found

  • Design: Editorial (commissioned opinion piece drawing on other published studies; not original research)
  • Who was studied: No study population; the editorial discusses people exposed to asbestos in Australia in general
  • Exposure: Asbestos in general, including exposure in mining, milling and product manufacture, product use, building repair, renovation and demolition, and domestic exposure
  • Main results:
    • The authors stated, citing other work, that the presence of pleural plaques is not as such a risk factor for (pleural) malignant mesothelioma or bronchogenic cancer
    • Citing the Australian Mesothelioma Registry, the authors reported that overall mesothelioma rates in Australia had levelled off at around 50 per million per annum in men and tenfold less in women
    • The authors stated that claimants are increasingly presenting with mesothelioma arising solely from domestic exposure
    • The authors stated that asbestosis cannot be distinguished from diffuse interstitial pulmonary fibrosis of other or unknown cause except by evidence of asbestos exposure
    • Citing earlier epidemiological work, the authors stated that the risk of mesothelioma is doubled in first-degree relatives of index cases
    • The authors described mesothelioma as universally fatal, with a median survival of 9–12 months
    • The authors stated that liability issues in common law damages claims have largely been resolved across Australia and that most people with disabling asbestos-related disease are compensated
  • The authors' conclusion: The authors argued that, because awards of general damages differ among jurisdictions, there is a strong case to harmonise the approach to compensation nationally

Topics

The National Library of Medicine indexes this study under subjects our site covers: Lung cancer, Mesothelioma.

Medical terms in this study, explained in our Lexicon: Asbestos Exposure.

Browse more research in The Medical Journal of Australia, or return to medical research.

Cited on this site

How to cite it

Cite the study

A.W. Musk, N.H. de Klerk, A.K. Nowak. Asbestos exposure: challenges for Australian clinicians. The Medical Journal of Australia 2016;204(2):48-9. doi:10.5694/mja15.01072. PMID: 26821092.

Cite our summary

“Asbestos exposure: challenges for Australian clinicians.” AsbestosClaims.Law Library. https://asbestosclaims.law/library/research/asbestos-exposure-challenges-for-australian-clinicians.

ACL Doc numbers and their short links never change. See how to cite the Library.

Talk with an asbestos lawyer

Start with what you remember, and we'll take it from there.

This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.